Support the HRSA Women’s Initiative for Screening and Health (WISH) program in updating the Women’s Preventive Services Guidelines and helping put them into clinical practice.
Approach:
Funding: HHS, through HRSA, will award up to $1 million in fiscal year 2027 to one organization.
Coalition: The recipient will convene at least 10 multidisciplinary experts representing healthcare, public health, behavioral health, patient and consumer groups, and organizations serving medically underserved women.
Guideline review: The coalition will update or reaffirm recommendations using evidence reviews conducted under National Academies standards for trustworthy guidelines.
Community materials: The recipient will develop and distribute guideline information adapted for communities with limited resources.
Key Findings:
The funding opportunity is designated HRSA-27-072.
Applications are due through Grants.gov by 11:59 p.m. ET on January 8, 2027; applicants must have active SAM.gov and Grants.gov registrations.
A 2022 HHS report cited in the announcement estimated that approximately 58 million women had private insurance coverage for preventive services without cost sharing.
Interpretation:
The announcement describes WISH as supporting evidence-based revisions to HRSA-supported preventive services guidelines and their dissemination through clinical and community partnerships.
Limitations:
The announcement does not provide the full application requirements, award timeline, or detailed evaluation criteria.
It reports a funding opportunity and planned activities, not results from the guideline review or its implementation.
Conclusion:
The grant is intended to fund one organization to review the guidelines and support their use in clinical practice and communities.
The increasing incidence of endometrial cancer is placing greater emphasis on timely recognition of abnormal uterine bleeding, individualized risk assessment and prompt diagnostic evaluation.